VOLITIONRX LTD

Amendment
CIK: 0000093314·Biotechnology·DELAWARE·Filed: Jan 28, 2026
Total Offering

$22,650,000

Amount Sold

$22,650,000

Investors

1

First Sale

May 20, 2025

Offering Details

Type
Debt, Option to Acquire, Security to be Acquired, Other: Common Stock issuable upon conversion of Warrants and Senior Secured Convertible Promissory Notes
Exemptions
Rule 506(b)

Related Persons

NameRole
Cameron Reynolds
Executive Officer, Director
Terig Hughes
Executive Officer
Rodney Rootsaert
Executive Officer
Louise Batchelor
Executive Officer
Salvatore Thomas Butera
Executive Officer
Gael Forterre
Executive Officer
Jasmine Kway
Executive Officer
Jacob Micallef
Executive Officer
Gaetan Michel
Executive Officer
Nicholas Plummer
Executive Officer
Alan Colman
Director
Mickie Henshall
Director
Guy Archibald Innes
Director
Kim Nguyen
Director
Phillip Barnes
Director
Timothy I Still
Director
Ethel Rubin
Director

Company

VOLITIONRX LTD

1489 West Warm Springs Road, Suite 110

Henderson, NV, 89014

(512) 774-8930

SEC Filing

0001477932-26-000461

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free